Intriguingly, ANKRD22, which is upregulated after dopaminergic therapy in PD [18], was also upregulated after acupuncture treatment, highlighting the potential of ANKRD22 as a response biomarker to predict/monitor therapeutic effects in patients with PD. Here, ANKRD22 is linked to Parkinson disease.